A blood examination capable of identifying 12 different types of cancer is currently in development by researchers at a British university, as announced by the health secretary.
“Merely a few drops of blood could reveal the presence of lung, breast, or bladder cancer, thereby eliminating prolonged delays for tests and imaging,” stated Wes Streeting.
Scholars from the University of Southampton are set to spearhead a team focused on this innovative diagnostic instrument, the health secretary elaborated.
This initiative is part of a broader array of advancements, including tailored immunotherapy treatments, which may attract public and private sector funding amounting to £148 million.
Additional developments may encompass more affordable scanning technologies that assist in the early detection of cancer, along with artificial intelligence systems for cancer diagnosis based on data shared across the NHS, as indicated by the Department for Science, Innovation and Technology.
Research centers will be established at University College London, the University of Liverpool, the University of Bristol, the University of Glasgow, and the University of Edinburgh.
The financial support will aid in the production of “state-of-the-art treatments,” Mr. Streeting affirmed.
“Identifying cancer at an earlier stage” will also “enhance the economic expansion of the UK,” he added.
Please use Chrome browser for a more accessible video player
New scanner speeds up medical imaging
Peter Kyle, the secretary for science and technology, remarked that while emerging technologies promise the potential for “longer, healthier lives,” they also have the capacity to “generate significant investment in life sciences that will foster job creation, opportunities, and economic growth.”
Life sciences will be central to the International Investment Summit scheduled for 14 October, he noted.
Read more:
World’s first ovarian cancer vaccine being developed in UK
Kate hugs girl, 16, with rare form of cancer
“As a survivor of cancer, I understand how crucial early diagnosis and cutting-edge treatments are,” Mr. Streeting remarked.
“This funding will not only preserve lives but also solidify Britain’s reputation as a leader in life sciences and medical technology.”
